Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis

    Recruiting

    2 1
    Investigated Drugs:
    Bulgaria Croatia France Germany Greece Hungary +5
  • Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark France +11
  • Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    Croatia Czechia France Greece Hungary Italy +5
  • A Phase 2a Study Evaluating the Efficacy and Safety of MK-8690 in Adults with Moderately to Severely Active Ulcerative Colitis

    Recruiting

    2 1
    France Germany Greece Italy The Netherlands Poland
  • Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +9
  • Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium Germany Hungary Italy Poland
  • Mesalazine Monotherapy vs Continuing Thiopurines in Older Patients with Ulcerative Colitis in Long-Term Remission

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Spain
  • A study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis

    Recruiting

    1 1
    Investigated Drugs:
    Poland
  • A study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark Germany Italy Poland Spain
  • A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Denmark Germany Hungary Italy The Netherlands +3